Search results
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 7 days ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
Livelsberger Financial Advisory Acquires Shares of 4,103 Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 days agoLivelsberger Financial Advisory bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to its most recent 13F filing with ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 6 days agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Monday, Benzinga reports ...
Alnylam Pharmaceuticals reports promising heart disease trial data
Invezz· 1 hour agoAlnylam Pharmaceuticals Inc (NASDAQ: ALNY) opened more than 30% up on Monday after reporting...
Volatility Grips Stocks as Nvidia Rout Accelerates: Markets Wrap
Bloomberg via Yahoo Finance· 51 minutes ago(Bloomberg) -- A renewed bout of volatility gripped stocks as a plunge in Nvidia Corp. raised...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 7 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 2 days agoThese acquisitions haven't hindered Pfizer's dividend payouts. The drugmaker distributed $2.4 billion in dividends to shareholders in the first quarter of 2024, and it intends ...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 2 days agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 6 days agoMerck set the price of Capvaxive at $287 per the single dose used for immunization. In a statement,...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoBiotech stocks hit a two-year high in February, but have trended sideways in the months since...